These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 1382045

  • 1. Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Baudouin C, Brignole F, Fredj-Reygrobellet D, Nègre F, Bayle J, Gastaud P.
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2822-9. PubMed ID: 1382045
    [Abstract] [Full Text] [Related]

  • 2. Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy.
    Baudouin C, Brignole F, Bayle J, Fredj-Reygrobellet D, Lapalus P, Gastaud P.
    Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):2065-72. PubMed ID: 2055699
    [Abstract] [Full Text] [Related]

  • 3. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy.
    Baudouin C, Fredj-Reygrobellet D, Brignole F, Nègre F, Lapalus P, Gastaud P.
    Ophthalmic Res; 1993 Jun; 25(1):52-9. PubMed ID: 8446368
    [Abstract] [Full Text] [Related]

  • 4. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, Planck SR, Rosenbaum JT.
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [Abstract] [Full Text] [Related]

  • 5. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC, La Heij EC, Diederen RM, Kessels AG, Liem AT, Kijlstra A, Hendrikse F.
    Ophthalmic Res; 2007 Sep; 39(3):148-54. PubMed ID: 17534114
    [Abstract] [Full Text] [Related]

  • 6. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
    Briggs MC, Grierson I, Hiscott P, Hunt JA.
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
    [Abstract] [Full Text] [Related]

  • 7. [Immunomorphological study of the vitreous body and subretinal fluid in vitreoretinal proliferation].
    Baudouin C, Brignole F, Bayle J, Fredj-Reygrobellet D, Lapalus P, Gastaud P.
    J Fr Ophtalmol; 1991 Sep; 14(3):147-52. PubMed ID: 1918821
    [Abstract] [Full Text] [Related]

  • 8. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M, Rollín R, Mediero A, Martínez-Montero JC, Fernández-Cruz A, Bravo-Llata C, Fernández-Durango R.
    Mol Vis; 2005 Jul 07; 11():461-71. PubMed ID: 16030497
    [Abstract] [Full Text] [Related]

  • 9. Subretinal membranes in proliferative vitreoretinopathy. An immunohistochemical study.
    García-Arumí J, Corcostegui B, Tallada N.
    Retina; 1992 Jul 07; 12(3 Suppl):S55-9. PubMed ID: 1280852
    [Abstract] [Full Text] [Related]

  • 10. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
    Casaroli-Marano RP, Pagan R, Vilaró S.
    Invest Ophthalmol Vis Sci; 1999 Aug 07; 40(9):2062-72. PubMed ID: 10440262
    [Abstract] [Full Text] [Related]

  • 11. Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro.
    Hunt RC, Davis AA.
    J Cell Physiol; 1990 Nov 07; 145(2):187-99. PubMed ID: 1700982
    [Abstract] [Full Text] [Related]

  • 12. Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Baudouin C, Brignole F, Gastaud P.
    Arch Ophthalmol; 1991 Sep 07; 109(9):1195-6. PubMed ID: 1929946
    [No Abstract] [Full Text] [Related]

  • 13. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis.
    Esser P, Heimann K, Bartz-schmidt KU, Fontana A, Schraermeyer U, Thumann G, Weller M.
    Exp Eye Res; 1997 Sep 07; 65(3):365-78. PubMed ID: 9299173
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.
    Lashkari K, Rahimi N, Kazlauskas A.
    Invest Ophthalmol Vis Sci; 1999 Jan 07; 40(1):149-56. PubMed ID: 9888438
    [Abstract] [Full Text] [Related]

  • 15. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L, Xu Y, Yu W, Li Y, Chu L, Dong J, Li X.
    Invest Ophthalmol Vis Sci; 2010 Jun 07; 51(6):3193-204. PubMed ID: 20071679
    [Abstract] [Full Text] [Related]

  • 16. Pathogenesis of proliferative vitreoretinopathy. Modulation of retinal pigment epithelial cell functions by vitreous and macrophages.
    Kirchhof B, Sorgente N.
    Dev Ophthalmol; 1989 Jun 07; 16():1-53. PubMed ID: 2676632
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy.
    Esser P, Tervooren D, Heimann K, Kociok N, Bartz-Schmidt KU, Walter P, Weller M.
    Invest Ophthalmol Vis Sci; 1998 Jan 07; 39(1):164-70. PubMed ID: 9430558
    [Abstract] [Full Text] [Related]

  • 18. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR.
    Behar-Cohen FF, Thillaye-Goldenberg B, de Bizemont T, Savoldelli M, Chauvaud D, de Kozak Y.
    Invest Ophthalmol Vis Sci; 2000 Nov 07; 41(12):3915-24. PubMed ID: 11053294
    [Abstract] [Full Text] [Related]

  • 19. Quantitative assessment of growth stimulating activity of the vitreous during PVR.
    Yang CM, Cousins SW.
    Invest Ophthalmol Vis Sci; 1992 Jul 07; 33(8):2436-42. PubMed ID: 1634341
    [Abstract] [Full Text] [Related]

  • 20. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
    Martini B.
    Acta Ophthalmol Suppl (1985); 1992 Jul 07; (201):1-63. PubMed ID: 1322004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.